ID   H-CB-P1
AC   CVCL_B0MU
DR   Wikidata; Q108820352
RX   Patent=DD295985B5;
RX   Patent=WO2004031383A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2104.
CC   Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0517.
CC   Monoclonal antibody isotype: IgM, lambda.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=DD295985B5;
RA   Jahn S., Bohn J., Settmacher U., Reipert B., Volk H.-D.,
RA   von Baehr R.;
RT   "Anti-tumor cell agents.";
RL   Patent number DD295985B5, 26-Jan-1995.
//
RX   Patent=WO2004031383A1;
RA   Sandig V., Winkler K., Marx U., Wermelinger T.;
RT   "High yield heterologous expression cell lines for expression of gene
RT   products with human glycosylation pattern.";
RL   Patent number WO2004031383A1, 15-Apr-2004.
//